var data={"title":"Classification and diagnosis of gastritis and gastropathy","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Classification and diagnosis of gastritis and gastropathy</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/contributors\" class=\"contributor contributor_credentials\">Mark Feldman, MD, MACP, AGAF, FACG</a></dd><dd><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/contributors\" class=\"contributor contributor_credentials\">Pamela J Jensen, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/contributors\" class=\"contributor contributor_credentials\">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 07, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gastritis is predominantly an inflammatory process, while the term gastropathy denotes a gastric mucosal disorder with minimal to no inflammation. The term gastritis is occasionally used to denote inflammation associated mucosal injury. However, epithelial cell injury and regeneration are not always accompanied by mucosal inflammation. This distinction has caused considerable confusion since the term &quot;gastritis&quot; is often used to describe endoscopic or radiologic characteristics of the gastric mucosa rather than specific histologic findings. Epithelial cell damage and regeneration with minimal or no associated inflammation is properly referred to as &quot;gastropathy.&quot; An etiology-based classification of gastropathy and gastritis is presented (<a href=\"image.htm?imageKey=GAST%2F91372\" class=\"graphic graphic_table graphicRef91372 \">table 1</a>).</p><p>The causes, natural history, and therapeutic implications of gastropathy differ from gastritis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gastritis is commonly secondary to infectious or autoimmune etiologies.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gastropathy is commonly secondary to endogenous or exogenous irritants, such as bile reflux, alcohol, or <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> and nonsteroidal antiinflammatory drugs. However, gastropathy can also be secondary to ischemia, physical stress, or chronic congestion.</p><p/><p>&quot;Gastritis&quot; is a term often used by endoscopists to describe an abnormal-appearing gastric mucosa rather than representing a particular endoscopic entity. A gastric mucosal biopsy is necessary to establish a definitive diagnosis of gastritis versus gastropathy.</p><p>This topic review will discuss the classification and diagnosis of gastritis and gastropathy. The causes of acute and chronic gastritis are presented separately.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLASSIFICATION OF GASTRITIS AND GASTROPATHY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no universally accepted classification of <span class=\"nowrap\">gastritis/gastropathy,</span> although several classifications (such as the Sydney system and the Operative Link for Gastritis Assessment [OLGA] staging system) have been proposed [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/1-12\" class=\"abstract_t\">1-12</a>]. The updated Sydney system does not yield actionable prognostic information concerning cancer risk in cases of chronic atrophic gastritis. The OLGA staging system may provide information about the risk of secondary gastric cancers in autoimmune gastritis [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/7,8\" class=\"abstract_t\">7,8</a>]. The OLGA staging system, which was proposed by an international group of pathologists for use in standardizing classification of atrophic gastritis, incorporates histologic phenotypes with extent of disease to aid in prediction of cancer risks [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/9\" class=\"abstract_t\">9</a>]. High stage disease (OLGA <span class=\"nowrap\">III/IV)</span> is associated with a high risk of gastric cancer. Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM), another proposed system, shows less interobserver variability and is prognostically useful [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/7,8,10\" class=\"abstract_t\">7,8,10</a>]. However, OLGIM may be less sensitive than OLGA in identifying high-risk gastritis, and some experts recommend using a combination of OLGA and OLGIM for staging of chronic gastritis [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/11\" class=\"abstract_t\">11</a>]. Gastritis has been classified by histologic features, time course (acute versus chronic), etiology, and proposed pathophysiology. (See <a href=\"topic.htm?path=gastric-intestinal-metaplasia#H2409463\" class=\"medical medical_review\">&quot;Gastric intestinal metaplasia&quot;, section on 'Definitions'</a>.)</p><p>However, classification remains controversial because of gaps in knowledge of etiology and pathogenesis, variation in nomenclature, and the frequent coexistence of more than one type of gastritis or gastropathy in individual patients. Furthermore, the entities overlap morphologically, and so some conditions are classified by etiology and others by morphologic pattern. Thus, comparisons across studies using different nomenclature can be difficult. There are many cases with a diagnosis of chronic gastritis (often mild) for which a specific etiology cannot be determined by histopathologic examination [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/13\" class=\"abstract_t\">13</a>].</p><p>Most classification systems distinguish acute, short-term disease from chronic, long-term disease. The terms acute and chronic are also used to describe the type of inflammatory cell infiltrate. Acute inflammation is represented by neutrophilic infiltration, while chronic inflammation is characterized by a mixture of mononuclear cells, chiefly lymphocytes, plasma cells, and macrophages.</p><p>A clinicopathologic framework for the classification of gastritis and gastropathy based upon these factors has been proposed (<a href=\"image.htm?imageKey=GAST%2F91372\" class=\"graphic graphic_table graphicRef91372 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/12\" class=\"abstract_t\">12</a>]. </p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A mucosal biopsy is required to distinguish between acute, chronic active, or chronic gastritis from gastropathy, since the endoscopic and radiologic features may be similar and clinical features are often inaccurate for predicting histologic findings [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/14-21\" class=\"abstract_t\">14-21</a>]. Histologic findings can vary over a wide spectrum ranging from epithelial hyperplasia to extensive epithelial cell damage with infiltration by inflammatory cells.</p><p>An illustrative study included 488 adults who were randomly selected from the general population and were screened by gastroscopy and biopsy [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/20\" class=\"abstract_t\">20</a>]. The authors determined the sensitivity and specificity of macroscopic features (including erythema, mucosal erosions, the absence of rugal folds, and the presence of visible vessels) compared with histologic findings. None of these endoscopic findings had sensitivity greater than 57 percent for determining the presence of gastritis or <em>Helicobacter pylori</em> infection. Another problem with relying on endoscopy alone is the interobserver variability for some features of gastropathy, such as erythema [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/19\" class=\"abstract_t\">19</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Laboratory evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Two types of laboratory tests have proven to be useful for predicting gastric mucosal findings: noninvasive testing for <em>H. pylori</em> infection and serologic biomarker measurements, both biochemical and immunologic.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Helicobacter pylori testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Noninvasive testing for <em>H. pylori</em> has high sensitivity and specificity for gastritis. (See <a href=\"topic.htm?path=acute-and-chronic-gastritis-due-to-helicobacter-pylori\" class=\"medical medical_review\">&quot;Acute and chronic gastritis due to Helicobacter pylori&quot;</a> and <a href=\"topic.htm?path=indications-and-diagnostic-tests-for-helicobacter-pylori-infection\" class=\"medical medical_review\">&quot;Indications and diagnostic tests for Helicobacter pylori infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Stomach-specific biochemical markers</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serum pepsinogens (PGs) have been used to screen patients for gastric atrophy. PG I is secreted only by oxyntic glands of the gastric fundus and body, whereas PG II is secreted by all gastric glands (oxyntic, cardiac and pyloric) as well as duodenal (Brunner's) glands. Thus, in conditions associated with gastritis of the fundus (as in pernicious anemia), PG I concentrations are decreased relative to PG II.</p><p>Low serum PG I levels are also strongly associated with extensive intestinal metaplasia [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/22\" class=\"abstract_t\">22</a>]. Intestinal metaplasia was found in 58 (88 percent) of 66 patients with a serum PG I value of less than 25 ng per milliliter [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/23\" class=\"abstract_t\">23</a>]. The ratio of PG isozymes I and II in serum has good correlation with presence of metaplastic atrophic gastritis (principally autoimmune metaplastic atrophic gastritis and pernicious anemia) [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/24\" class=\"abstract_t\">24</a>]. Measurement of serum gastrin evaluated in tandem with PG I:II ratio has been advocated to reflect the degree of inflammation and grade of atrophic gastritis [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/25\" class=\"abstract_t\">25</a>]. The early diagnosis of atrophic gastritis is important as this condition is a significant independent risk factor for the development of distal gastric tumors, both adenocarcinoma and carcinoid [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/8,25\" class=\"abstract_t\">8,25</a>]. (See <a href=\"topic.htm?path=metaplastic-chronic-atrophic-gastritis#H9\" class=\"medical medical_review\">&quot;Metaplastic (chronic) atrophic gastritis&quot;, section on 'Neoplastic lesions'</a>.)</p><p>The ratio of serum PG I:II in the serum of people with normal gastric mucosa is approximately 6.2 [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/26\" class=\"abstract_t\">26</a>]. In one series, the presence of fundic atrophic gastritis was accurately predicted by the concentration of PG I and the ratio of PG isoenzymes in approximately 70 percent of patients [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/26\" class=\"abstract_t\">26</a>]. The ratio may also be useful for screening family members of patients with pernicious anemia and for identifying patients at high risk for gastric cancer in endemic countries or other populations at increased risk for gastric atrophy [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/26-29\" class=\"abstract_t\">26-29</a>]. On the other hand, measurement of serum PGs and their ratio do not accurately discriminate nonatrophic versus <span class=\"nowrap\">antrum-restricted/predominant</span> atrophic gastritis in an asymptomatic population or first-degree relatives of patients with gastric cancer [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/30,31\" class=\"abstract_t\">30,31</a>]. (See <a href=\"topic.htm?path=gastric-cancer-screening\" class=\"medical medical_review\">&quot;Gastric cancer screening&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H464891811\"><span class=\"h3\">Serologic immunologic markers</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immunological markers may be useful in clinically asymptomatic patients with early autoimmune gastritis (AIG) [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/32\" class=\"abstract_t\">32</a>]. Testing for antibodies to intrinsic factor, parietal cells, and <em>H. pylori</em> in tandem with serum gastrin may provide noninvasive early evidence of autoimmune gastritis and facilitate selection of patients for endoscopic examination [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Accurate histologic assessment of gastritis and gastropathy depends upon optimizing the site and number of biopsy specimens. Magnification endoscopy may help in the identification of areas to biopsy. (See <a href=\"topic.htm?path=magnification-endoscopy\" class=\"medical medical_review\">&quot;Magnification endoscopy&quot;</a>.)</p><p>Biopsy site preferences and number vary in clinical practice. However, there is general consensus among experts on the following biopsy approach [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/12\" class=\"abstract_t\">12</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>All gross abnormalities should be biopsied and submitted in separate containers.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Normal-appearing mucosa adjacent to the lesional tissue should also be biopsied.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple biopsies (two to five) of both the corpus and the antrum should be obtained when attempting to establish the diagnosis of <em>H. pylori</em> or autoimmune gastritis.</p><p/><p>Biopsy of the incisura is also useful since it approximates the transition zone between the antrum and body, where intestinal metaplasia and atrophy are most frequently found in patients with environmental metaplastic atrophic gastritis. However, biopsy of the incisura alone does not provide information on the extent of metaplastic atrophic gastritis, which is a major parameter in determination of cancer risk [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/8,10\" class=\"abstract_t\">8,10</a>].</p><p>In first-degree relatives of patients with early onset gastric carcinoma (age &lt;45 years), endoscopic evaluation with at least four biopsies from the gastric antrum and corpus is suggested. Multiple biopsies with adequate sampling are necessary for scoring and staging of premalignant lesions in this subgroup of patients [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/8\" class=\"abstract_t\">8</a>].</p><p>Biopsies of the duodenum may also be helpful for diagnosing some forms of chronic gastritis. As examples, duodenal biopsies may show evidence of Crohn disease in patients with granulomatous gastritis or of celiac disease in patients with lymphocytic gastritis.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Communication with the pathologist</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Good communication between the endoscopist and pathologist cannot be overemphasized, and will optimize the interpretation of the biopsy specimens. This has become greatly facilitated by the availability of digital endoscopic pictures and readily available endoscopic procedural dictation in the electronic medical record.</p><p>The pathologist should include a morphologic classification of the gastritis or gastropathy in the biopsy report (<a href=\"image.htm?imageKey=GAST%2F80329\" class=\"graphic graphic_table graphicRef80329 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/33\" class=\"abstract_t\">33</a>].</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=gastritis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Gastritis (The Basics)&quot;</a> and <a href=\"topic.htm?path=upper-endoscopy-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Upper endoscopy (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=upper-endoscopy-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Upper endoscopy (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gastric inflammatory disease can be broadly categorized into gastritis and gastropathy. Gastritis is predominantly an inflammatory process while gastropathy denotes gastric mucosal pathology with minimal to no inflammation. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no universally accepted classification of <span class=\"nowrap\">gastritis/gastropathy,</span> although several classifications of gastritis and gastropathy have been proposed (<a href=\"image.htm?imageKey=GAST%2F91372\" class=\"graphic graphic_table graphicRef91372 \">table 1</a>). (See <a href=\"#H3\" class=\"local\">'Classification of gastritis and gastropathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A mucosal biopsy is required to distinguish acute, chronic active, and chronic gastritis and gastropathy. (See <a href=\"#H4\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is general consensus among experts on a biopsy approach. (See <a href=\"#H8\" class=\"local\">'Biopsy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Good communication between the endoscopist and pathologist cannot be overemphasized, and will optimize the interpretation of the biopsy specimens. (See <a href=\"#H9\" class=\"local\">'Communication with the pathologist'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H26013992\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Beverly Dickson, MD, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/1\" class=\"nounderline abstract_t\">Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6:209.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/2\" class=\"nounderline abstract_t\">Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988; 83:504.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/3\" class=\"nounderline abstract_t\">Wyatt JI, Dixon MF. Chronic gastritis--a pathogenetic approach. J Pathol 1988; 154:113.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/4\" class=\"nounderline abstract_t\">Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/5\" class=\"nounderline abstract_t\">Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995; 108:917.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/6\" class=\"nounderline abstract_t\">Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56:631.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/7\" class=\"nounderline abstract_t\">Rugge M, Fassan M, Pizzi M, et al. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012; 35:1460.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/8\" class=\"nounderline abstract_t\">Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, et al. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012; 35:1451.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/9\" class=\"nounderline abstract_t\">Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008; 40:650.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/10\" class=\"nounderline abstract_t\">Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 2013; 77:284.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/11\" class=\"nounderline abstract_t\">Isajevs S, Liepniece-Karele I, Janciauskas D, et al. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch 2014; 464:403.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/12\" class=\"nounderline abstract_t\">Dixon MF, Genta RM, Yardley JH, Correa P. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997; 2 Suppl 1:S17.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/13\" class=\"nounderline abstract_t\">Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med 2008; 132:1586.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/14\" class=\"nounderline abstract_t\">Khakoo SI, Lobo AJ, Shepherd NA, Wilkinson SP. Histological assessment of the Sydney classification of endoscopic gastritis. Gut 1994; 35:1172.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/15\" class=\"nounderline abstract_t\">Cronstedt JL, Simson IW. Correlation between gastroscopic and direct vision biopsy findings. Gastrointest Endosc 1973; 19:174.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/16\" class=\"nounderline abstract_t\">Elta GH, Appelman HD, Behler EM, et al. A study of the correlation between endoscopic and histological diagnoses in gastroduodenitis. Am J Gastroenterol 1987; 82:749.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/17\" class=\"nounderline abstract_t\">J&ouml;nsson KA, Gotthard R, Bodemar G, Brodin U. The clinical relevance of endoscopic and histologic inflammation of gastroduodenal mucosa in dyspepsia of unknown origin. Scand J Gastroenterol 1989; 24:385.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/18\" class=\"nounderline abstract_t\">Tytgat GN. The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 1991; 6:223.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/19\" class=\"nounderline abstract_t\">Laine L, Cohen H, Sloane R, et al. Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers. Gastrointest Endosc 1995; 42:420.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/20\" class=\"nounderline abstract_t\">Red&eacute;en S, Petersson F, J&ouml;nsson KA, Borch K. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy 2003; 35:946.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/21\" class=\"nounderline abstract_t\">Kaur G, Raj S. A study of the concordance between endoscopic gastritis and histological gastritis in an area with a low background prevalence of Helicobacter pylori infection. Singapore Med J 2002; 43:90.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/22\" class=\"nounderline abstract_t\">Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007; 8:8.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/23\" class=\"nounderline abstract_t\">Urita Y, Hike K, Torii N, et al. Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004; 49:795.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/24\" class=\"nounderline abstract_t\">Samloff IM. Peptic ulcer: the many proteinases of aggression. Gastroenterology 1989; 96:586.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/25\" class=\"nounderline abstract_t\">Agr&eacute;us L, Kuipers EJ, Kupcinskas L, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012; 47:136.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/26\" class=\"nounderline abstract_t\">Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83:204.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/27\" class=\"nounderline abstract_t\">Yoshihara M, Sumii K, Haruma K, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93:1090.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/28\" class=\"nounderline abstract_t\">Graham DY, Nurgalieva ZZ, El-Zimaity HM, et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 2006; 4:306.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/29\" class=\"nounderline abstract_t\">Oishi Y, Kiyohara Y, Kubo M, et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 2006; 163:629.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/30\" class=\"nounderline abstract_t\">Ricci C, Vakil N, Rugge M, et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004; 99:1910.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/31\" class=\"nounderline abstract_t\">Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008; 6:174.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/32\" class=\"nounderline abstract_t\">Antico A, Tampoia M, Villalta D, et al. Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis. Clin Dev Immunol 2012; 2012:520970.</a></li><li><a href=\"https://www.uptodate.com/contents/classification-and-diagnosis-of-gastritis-and-gastropathy/abstract/33\" class=\"nounderline abstract_t\">Owen DA. Gastritis and carditis. Mod Pathol 2003; 16:325.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 29 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H10\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLASSIFICATION OF GASTRITIS AND GASTROPATHY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">DIAGNOSIS</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Laboratory evaluation</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Helicobacter pylori testing</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Stomach-specific biochemical markers</a></li><li><a href=\"#H464891811\" id=\"outline-link-H464891811\">- Serologic immunologic markers</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">Biopsy</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Communication with the pathologist</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H86361287\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H26013992\" id=\"outline-link-H26013992\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/29|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/91372\" class=\"graphic graphic_table\">- Etiology-based classification of gastropathy and gastritis</a></li><li><a href=\"image.htm?imageKey=GAST/80329\" class=\"graphic graphic_table\">- Morphology gastritis or gastropathy</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-and-chronic-gastritis-due-to-helicobacter-pylori\" class=\"medical medical_review\">Acute and chronic gastritis due to Helicobacter pylori</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastric-cancer-screening\" class=\"medical medical_review\">Gastric cancer screening</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastric-intestinal-metaplasia\" class=\"medical medical_review\">Gastric intestinal metaplasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=indications-and-diagnostic-tests-for-helicobacter-pylori-infection\" class=\"medical medical_review\">Indications and diagnostic tests for Helicobacter pylori infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=magnification-endoscopy\" class=\"medical medical_review\">Magnification endoscopy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=metaplastic-chronic-atrophic-gastritis\" class=\"medical medical_review\">Metaplastic (chronic) atrophic gastritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastritis-the-basics\" class=\"medical medical_basics\">Patient education: Gastritis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=upper-endoscopy-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Upper endoscopy (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=upper-endoscopy-the-basics\" class=\"medical medical_basics\">Patient education: Upper endoscopy (The Basics)</a></li></ul></div></div>","javascript":null}